BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1625532)

  • 1. The clinical use of histamine-2 receptor antagonists.
    Michocki RJ; Richardson JP
    Md Med J; 1992 May; 41(5):397-400. PubMed ID: 1625532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Famotidine in gastroesophageal reflux disease (GERD).
    Wesdorp IC
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():24-6. PubMed ID: 1577391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastroesophageal reflux and histamine2 antagonists.
    Bell SG
    Neonatal Netw; 2003; 22(2):53-7. PubMed ID: 12696725
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ; Fennerty B; Fagan TC
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term treatment of peptic ulcer with histamine H2 receptor blockaders: results of their use and new problems].
    Grigor'ev PIa; Isakov VA
    Klin Med (Mosk); 1991 Oct; 69(10):93-7. PubMed ID: 1685004
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug therapy of peptic ulcer disease.
    Ching CK; Lam SK
    Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
    Saha N; Sachdev A; Bhasin DK; Sankaranahyanan A; Khosla PP; Singh K; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1993 Jul; 31(7):322-5. PubMed ID: 8103763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do H2 receptor antagonists have a therapeutic role in childhood?
    Kelly DA
    J Pediatr Gastroenterol Nutr; 1994 Oct; 19(3):270-6. PubMed ID: 7815256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
    Savarino V
    Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of gastroesophageal reflux disease].
    Herszényi L
    Orv Hetil; 2003 Dec; 144(52):2571-3. PubMed ID: 15005067
    [No Abstract]   [Full Text] [Related]  

  • 11. Implementing therapeutic interchange of intravenous famotidine for cimetidine and ranitidine.
    Oh T; Franko TG
    Am J Hosp Pharm; 1990 Jul; 47(7):1547-51. PubMed ID: 2114789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacology of H2-receptor antagonists: an overview.
    Schunack W
    J Int Med Res; 1989; 17 Suppl 1():9A-16A. PubMed ID: 2566544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative evaluation of cimetidine and ranitidine.
    Zimmerman TW; Schenker S
    Ration Drug Ther; 1985 Apr; 19(4):1-7. PubMed ID: 2932770
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine.
    Adachi K; Komazawa Y; Mihara T; Azumi T; Fujisawa T; Katsube T; Furuta K; Kinoshita Y
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1012-5. PubMed ID: 15955208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of peptic ulcer maintenance trials.
    Robinson M
    Am J Med; 1984 Nov; 77(5B):23-9. PubMed ID: 6095657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the H2 histamine receptor antagonist on oxygen metabolism in some morphotic blood elements in patients with ulcer disease.
    Kedziora-Kornatowska K; Tkaczewski W; Blaszczyk J; Buczynski A; Chojnacki J; Kedziora J
    Hepatogastroenterology; 1998; 45(19):276-80. PubMed ID: 9496526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical importance of the new H2-antagonists.
    Walt RP
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():97-9. PubMed ID: 2566730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [H2 receptor antagonists and intragastric acidity].
    Dammann HG; Walter TA; Müller P; Simon B
    Dtsch Med Wochenschr; 1984 Nov; 109(46):1767-9. PubMed ID: 6094136
    [No Abstract]   [Full Text] [Related]  

  • 19. H2-receptor antagonists and duodenal ulcer recurrence: analysis of efficacy and commentary on safety, costs, and patient selection.
    Freston JW
    Am J Gastroenterol; 1987 Dec; 82(12):1242-9. PubMed ID: 2891294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
    Kuipers EJ; Hazenberg HJ; Quik RF; Hazenberg BP; de Zwart PA
    Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.